Log in to save to my catalogue

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9922d9f362cb422ca19401f860eaed83

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

About this item

Full title

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-09, Vol.10 (1), p.4355-12, Article 4355

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Genetically engineered T cells expressing a chimeric antigen receptor (CAR) are rapidly emerging a promising new treatment for haematological and non-haematological malignancies. CAR-T therapy can induce rapid and durable clinical responses but is associated with unique acute toxicities. Moreover, CAR-T cells are vulnerable to immunosuppressive mec...

Alternative Titles

Full title

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9922d9f362cb422ca19401f860eaed83

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9922d9f362cb422ca19401f860eaed83

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-12321-3

How to access this item